FDA clearedNeuro Oncology

Perfusion imaging

By October 8, 2018 October 9th, 2018 No Comments

Perfusion imaging quantifies the characteristics of blood flow in tissues: Dynamic susceptibility contrast MRI quantifies relative cerebral blood volume. These quantitative maps offer information to predict tumor grade and analyze post treatment changes for glioblastoma multiforme, meningioma, astrocytoma and oligodendroglioma.


  • Çoban, G., et al. “Prognostic value of dynamic susceptibility contrast-enhanced and diffusion-weighted MR imaging in patients with glioblastomas.” American Journal of Neuroradiology (2015).
  • Lee, B., et al. “Clinical Value of Vascular Permeability Estimates Using Dynamic Susceptibility Contrast MRI: Improved Diagnostic Performance in Distinguishing Hypervascular Primary CNS Lymphoma from Glioblastoma.” American Journal of Neuroradiology (2018).


  • IB Neuro – FDA cleared, CE marked
  • DSC-MRI analysis tool (Imaging Biometrics)

FDA cleared: FDA cleared

Company: Imaging Biometrics

Leave a Reply